Beside the previously mentioned disorders, RBP4 and retinoids are also associated with pro-atherogenic lipid profile, especially with hypertriglyceridemia in subjects with high type 2 diabetes risk [110]. Here, RBP4 is linked to type 2 diabetes mellitus.